Zhuang Li, et al. [31] developed a five-gene signature (KIF15, NAT2, GPX3, SCG2, and CLCA1) for predicting the OS of CRC patients in two independent GEO cohorts. The gene discussed is NAT2; the disease is colorectal carcinoma.